Tag: baxter

Biologics

Baxter to acquire Synovis

Baxter International Inc. (NYSE:BAX) and Synovis Life Technologies, Inc. (NASDAQ:SYNO) today announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical products for soft tissue repair used in a variety of surgical procedures. The acquisition complements and will expand the portfolio of Baxter’s regenerative […]

Ceremed sells Ostene to Baxter
Biologics

Ceremed sells Ostene to Baxter

Ceremed, Inc. (Los Angeles) announced today that it has entered into a definitive agreement to sell its Ostene® brand bone hemostasis product line to Baxter International Inc.  The agreement provides for Baxter to acquire all rights to the Ostene® brand, including manufacturing. Founded in 2002, Ceremed is a privately held […]

Baxter Acquires Apatech
Uncategorized

Baxter Acquires Apatech

It was announced today that Baxter has done something Stryker seemingly has been unable (or unwilling) to. They have entered into a definitive agreement to acquire Apatech. Many people have responded to this news saying, “Baxter did what?”

Ultimately, the deal breaks down as $240 million now and an additional $90 million based on milestones.

Biologics

Baxter and ApaTech Announce Definitive Agreement

DEERFIELD, Ill. & LONDON–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global, diversified healthcare company, and ApaTech, a private equity-backed, U.K.-based orthobiologic products company, today announced a definitive agreement whereby Baxter will acquire all of the outstanding equity of ApaTech for total consideration of up to $330 million. As a result of […]